Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy

K Dzierlega, T Yokota - Gene therapy, 2020 - nature.com
Duchenne muscular dystrophy (DMD) is one of the most common lethal muscle-wasting
disorders affecting young boys caused by mutations in the DMD gene. Exon skipping has …

Disrupted calcium homeostasis in duchenne muscular dystrophy: A common mechanism behind diverse consequences

B Zabłocka, DC Górecki, K Zabłocki - International Journal of Molecular …, 2021 - mdpi.com
Duchenne muscular dystrophy (DMD) leads to disability and death in young men. This
disease is caused by mutations in the DMD gene encoding diverse isoforms of dystrophin …

[HTML][HTML] Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants

T Brandt, LM Sack, D Arjona, D Tan, H Mei, H Cui… - Genetics in …, 2020 - Elsevier
Purpose The ability of a single technology, next-generation sequencing, to provide both
sequence and copy number variant (CNV) results has driven the merger of clinical …

Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo

J Li, K Wang, Y Zhang, T Qi, J Yuan, L Zhang, H Qiu… - Circulation, 2021 - Am Heart Assoc
Background: Loss of dystrophin protein causes Duchenne muscular dystrophy (DMD),
characterized by progressive degeneration of cardiac and skeletal muscles, and mortality in …

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse

N Wein, TA Vetter, A Vulin, TR Simmons… - … Therapy-Methods & …, 2022 - cell.com
Duchenne muscular dystrophy (DMD) is typically caused by mutations that disrupt the DMD
reading frame, but nonsense mutations in the 5′ part of the gene induce utilization of an …

Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs)

K Nagel-Wolfrum, F Möller, I Penner, T Baasov… - BioDrugs, 2016 - Springer
In recent years, remarkable advances in the ability to diagnose genetic disorders have been
made. The identification of disease-causing genes allows the development of gene-specific …

The multifaceted view of heart problem in Duchenne muscular dystrophy

U Florczyk-Soluch, K Polak, J Dulak - Cellular and Molecular Life Sciences, 2021 - Springer
Dystrophin is a large protein serving as local scaffolding repetitively bridging cytoskeleton
and the outside of striated muscle cell. As such dystrophin is a critical brick primarily in …

The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene

A Torella, M Zanobio, R Zeuli, F del Vecchio Blanco… - PLoS …, 2020 - journals.plos.org
A nonsense mutation adds a premature stop signal that hinders any further translation of a
protein-coding gene, usually resulting in a null allele. To investigate the possible exceptions …

EMQN best practice guidelines for genetic testing in dystrophinopathies

C Fratter, R Dalgleish, SK Allen, R Santos… - European Journal of …, 2020 - nature.com
Dystrophinopathies are X-linked diseases, including Duchenne muscular dystrophy and
Becker muscular dystrophy, due to DMD gene variants. In recent years, the application of …

Pharmacological profile of viltolarsen for the treatment of duchenne muscular dystrophy: a Japanese experience

RR Roshmi, T Yokota - Clinical Pharmacology: Advances and …, 2021 - Taylor & Francis
Duchenne muscular dystrophy (DMD) is a fatal, X-linked recessive disorder characterized by
progressive muscle loss and cardiorespiratory complications. Mutations in the DMD gene …